Trupanion Inc (NASDAQ:TRUP) Director Murray B. Low sold 1,000 shares of the stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $24.59, for a total value of $24,590.00. Following the transaction, the director now owns 182,942 shares of the company’s stock, valued at $4,498,543.78. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.
Shares of TRUP opened at $31.48 on Friday. The company has a market cap of $836.35 million, a PE ratio of -1,049.33 and a beta of 1.50. The company has a quick ratio of 1.80, a current ratio of 1.80 and a debt-to-equity ratio of 0.15. Trupanion Inc has a 52-week low of $20.84 and a 52-week high of $37.13. The business has a fifty day moving average of $23.89 and a 200 day moving average of $29.27.
Trupanion (NASDAQ:TRUP) last announced its quarterly earnings results on Tuesday, November 5th. The financial services provider reported $0.02 EPS for the quarter, beating the consensus estimate of ($0.02) by $0.04. The firm had revenue of $99.28 million for the quarter, compared to analyst estimates of $97.24 million. Trupanion had a negative return on equity of 2.09% and a negative net margin of 0.75%. The business’s revenue for the quarter was up 27.0% on a year-over-year basis. During the same quarter last year, the firm posted $0.03 earnings per share. As a group, research analysts anticipate that Trupanion Inc will post -0.13 earnings per share for the current fiscal year.
TRUP has been the subject of a number of research reports. BidaskClub upgraded Trupanion from a “strong sell” rating to a “sell” rating in a research report on Saturday. Craig Hallum set a $20.00 target price on Trupanion and gave the company a “hold” rating in a research report on Friday, October 11th. TheStreet downgraded Trupanion from a “c” rating to a “d+” rating in a research report on Tuesday, July 30th. Royal Bank of Canada set a $38.00 target price on Trupanion and gave the company a “buy” rating in a research report on Wednesday, July 31st. Finally, Northland Securities reiterated a “buy” rating and set a $40.00 target price on shares of Trupanion in a research report on Wednesday. Two equities research analysts have rated the stock with a sell rating, one has assigned a hold rating and five have issued a buy rating to the stock. The stock has an average rating of “Hold” and an average target price of $36.00.
Trupanion Company Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels.
Read More: Roth IRA
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.